Hansa Biopharma AB

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

W4307Q109
SEDOL

BYQNPK5
CIK

N/A

hansabiopharma.com
LEI:
FIGI: BBG000QCYH36
HNSA

Hansa Biopharma AB
GICS: 35201010 · Sector: Health Care · Sub-Sector: Health Care
AI
PROFILER
NAME
Hansa Biopharma AB
ISIN
SE0002148817
TICKER
HNSA
MIC
XSTO
REUTERS
HNSA.ST
BLOOMBERG
HNSA SS
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
In this section you will find transaction histories for short sales.
ai
NALIZER
Short sellers are obliged to report when building up positions from 0.50% and when reducing positions up to 0.50%. If there are open positions >= 0.50% in the reporting registers, these are shown in the following overview.
Fifteen Short sale positions >= 0.50% are currently registered as reportable-relevant
Date Position Holder Position # Action
17.12.2024 ActusRayPartners Limited 0,50% 1
06.05.2024 Arrowstreet Capital Limited Partnership 0,69% 25
03.05.2024 GSA Capital Partners LLP 0,54% 11
05.02.2024 Citadel Advisors LLC 0,59% 35
09.01.2024 WORLDQUANT LLC 0,51% 67
06.11.2023 PDT Partners LLC 0,50% 12
25.08.2023 Voleon Capital Management LP 0,53% 67
16.09.2022 MILLENNIUM INTERNATIONAL MANAGEMENT LP 0,50% 8
03.05.2022 Marshall Wace LLP 0,50% 51
22.03.2022 Systematica Investments Limited 0,50% 8
21.10.2021 Capital Fund Management SA 0,50% 2
22.01.2021 Point72 Asset Management LP 0,50% 2
27.04.2020 Squarepoint Ops LLC 0,50% 20
27.11.2019 WORLDQUANT, LLC 0,50% 20
15.11.2018 MARSHALLWACE LLP 0,79% 1
The overview shows all positions and their last reported status. Please note that when reducing positions, falling below the 0.50% limit means that the mandatory reporting obligations no longer have to be applied. As a rule, it can be assumed that the positions have been completely reduced following a longer period of inactivity. Positions < 0.50% are therefore only of limited significance.
Date Position Holder Position # Action
17.12.2024 ActusRayPartners Limited 0,50% 1
06.05.2024 Arrowstreet Capital Limited Partnership 0,69% 25
03.05.2024 GSA Capital Partners LLP 0,54% 11
05.02.2024 Citadel Advisors LLC 0,59% 35
09.01.2024 WORLDQUANT LLC 0,51% 67
06.11.2023 PDT Partners LLC 0,50% 12
25.08.2023 Voleon Capital Management LP 0,53% 67
16.09.2022 MILLENNIUM INTERNATIONAL MANAGEMENT LP 0,50% 8
03.05.2022 Marshall Wace LLP 0,50% 51
22.03.2022 Systematica Investments Limited 0,50% 8
21.10.2021 Capital Fund Management SA 0,50% 2
22.01.2021 Point72 Asset Management LP 0,50% 2
27.04.2020 Squarepoint Ops LLC 0,50% 20
27.11.2019 WORLDQUANT, LLC 0,50% 20
15.11.2018 MARSHALLWACE LLP 0,79% 1
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S